Ketamine-Assisted Psychotherapy (KAP) is an innovative treatment that combines intravenous ketamine with psychotherapy in a carefully monitored clinical setting. At Senz, this treatment is being evaluated in an open-label clinical trial for individuals with persistent depression who have not responded sufficiently to previous treatments. The combination of ketamine, psychological support, and integration sessions aims to promote emotional processing, psychological flexibility, and lasting therapeutic change.
Eligibility
Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Adults (18 years and older)
* TRD
* A MADRS score above the established clinical cut-off, indicating clinically significant depressive symptoms
* Insufficient response to at least two adequate antidepressant treatment trials and one evidence-based psychotherapy, or failure to achieve adequate improvement following at least three consecutive treatment steps in accordance with the Dutch Multidisciplinary Guideline for Depression
Exclusion Criteria:
* Current substance use disorder or recent illicit drug use
* Substance use disorder not in remission for at least 3 months
* Inability to abstain from alcohol for 24 hours before and after treatment
* Acute suicidality
* Current or past psychotic disorder
* Significant neurological disorders (e.g., epilepsy, elevated intracranial pressure)
* Uncontrolled hypertension or medical conditions associated with increased cardiovascular or cerebrovascular risk (e.g., aneurysms, recent myocardial infarction or intracerebral hemorrhage)
* Significant bladder disease (e.g., cystitis)
* Severe hepatic impairment
* Pregnancy, breastfeeding, or ongoing IVF treatment
* Extreme underweight or obesity where treatment is deemed medically unsafe Inability to arrange an accompanying adult for transport and support after treatment
Primary outcome measure(s)
Beck Depression Inventory — baseline/pre-intervention/post-intervention (end of treatment)/3months after post-intervention depression self-report measure. Zero is equivalent to no depression and 64 indicates the highest score on depression.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.